In the 3rd and final episode of this series, we’ll be meeting with Georgios Tramountanis, a member of the MAPS Digital Focus Area Working Group to examine where we see potential opportunities for Medical Affairs as it relates to Automation and review some predictions on the future of Automation in Medical Affairs.
In the 2nd of this 3-part series, we’ll be meeting with Shinya Suda-san, Sr. Vice President and Global Head of Information Systems at Astellas to glean insights on Automation opportunities as it relates to Digital Transformation.
In this first of 3 episodes, we will be meeting with an industry expert on Automation within the pharmaceutical industry.
Digital tools power the ability of Medical Affairs teams to generate, analyze and disseminate data to external stakeholders across the product lifecycle, while bringing essential learnings from these stakeholders back to the organization in the form of insights.
MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
Medical technologies require equipping health care providers with the theoretical knowledge of best and safest use and also ensuring users’ practical competence. This article by the MAPS MedTech and External Education FAWGs overviews these best practices.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.
Here John Pracyk, MD, PhD, MBA, MAPS President of the Americas Region speaks with some of the top Medical Affairs leaders from Johnson & Johnson as they share their perspective on the impact of Digital on Healthcare.
This podcast focuses on publication metrics, specifically on how article-level metrics are impacting and creating new opportunities for medical publication and what metrics we should be tracking.
This podcast focuses on different forms of enhanced publication content (EPC) and new approaches that might change manuscript development.